Gene · 8174
Papers1,829
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,829
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Total flavone of flowers of Abelmoschus manihot (L.) Medic inhibits the expression of adhesion molecules in primary mesenteric arterial endothelial cells and ameliorates dextran sodium sulphate-induced ulcerative colitis in mice. | Phytomedicine | 2023 | 36857970 | PubTator, text mining | PubMed |
| MAdCAM-1 does not play a central role in the early pathophysiology of autoimmune hepatitis. | Clin Res Hepatol Gastroenterol | 2023 | 36841352 | PubTator, text mining | PubMed |
| Novel diagnostic biomarkers of T cell-mediated tumor killing characteristics for early-stage triple negative breast cancer: A SEER analysis and molecular portraits. | Medicine (Baltimore) | 2023 | 36827041 | PubTator, text mining | PubMed |
| Ozoile Reduces the LPS-Induced Inflammatory Response in Colonic Epithelial Cells and THP-1 Monocytes. | Curr Issues Mol Biol | 2023 | 36826032 | PubTator, text mining | PubMed |
| Differential Gene Expression Profiling in Alveolar Echinococcosis Identifies Potential Biomarkers Associated With Angiogenesis. | Open Forum Infect Dis | 2023 | 36817746 | PubTator, text mining | PubMed |
| Sialylation regulates migration in chronic lymphocytic leukemia. | Haematologica | 2023 | 36779594 | PubTator, text mining | PubMed |
| Apigenin and Exposure to Low Dose Gamma Radiation Ameliorate Acetic Acid-Induced Ulcerative Colitis in Rats. | Dose Response | 2023 | 36756150 | PubTator, text mining | PubMed |
| Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape. | J Adv Res | 2023 | 36736694 | PubTator, text mining | PubMed |
| Possible Efficacy of Vedolizumab, an Anti-α4β7 Integrin Antibody, in Palmoplantar Pustulosis. | Case Rep Dermatol | 2023 | 36726801 | PubTator, text mining | PubMed |
| Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis. | Sci Rep | 2023 | 36725872 | PubTator, text mining | PubMed |
| The use of therapeutic drug monitoring for early identification of vedolizumab response in Saudi Arabian patients with inflammatory bowel disease. | Sci Rep | 2023 | 36720977 | PubTator, text mining | PubMed |
| Depletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia. | Exp Hematol Oncol | 2023 | 36707896 | PubTator, text mining | PubMed |
| Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology. | World J Gastroenterol | 2023 | 36687128 | PubTator, text mining | PubMed |
| Modern drug discovery for inflammatory bowel disease: The role of computational methods. | World J Gastroenterol | 2023 | 36687123 | PubTator, text mining | PubMed |
| Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities. | World J Clin Cases | 2023 | 36686358 | PubTator, text mining | PubMed |
| A Reciprocal Link between Oral, Gut Microbiota during Periodontitis: The Potential Role of Probiotics in Reducing Dysbiosis-Induced Inflammation. | Int J Mol Sci | 2023 | 36674600 | PubTator, text mining | PubMed |
| New Developments in Celiac Disease Treatment. | Int J Mol Sci | 2023 | 36674460 | PubTator, text mining | PubMed |
| Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial Fibrillation. | Biomedicines | 2023 | 36672684 | PubTator, text mining | PubMed |
| Molecular Modeling Insights into the Structure and Behavior of Integrins: A Review. | Cells | 2023 | 36672259 | PubTator, text mining | PubMed |
| Transcriptional profiling of the developing rat ovary following intrauterine exposure to the endocrine disruptors diethylstilbestrol and ketoconazole. | Arch Toxicol | 2023 | 36653537 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8174/papers?page=13